What happened (actor, venue, action)?
Union Minister of State (Independent Charge) for Science and Technology and Earth Sciences, and MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr. Jitendra Singh, sought enhanced private sector participation in India’s biotechnology ecosystem. He discussed measures with senior officials of the Biotechnology Industry Research Assistance Council (BIRAC) in New Delhi, with a focus on faster commercialisation of indigenous biotechnology innovations.
Background and earlier position: why BIRAC-RDIF matters in biotech innovation financing
BIRAC-RDIF is a biotechnology-focused component within the Government of India’s ₹1 lakh crore Research, Development and Innovation (RDI) Fund. Government information in the PIB communication links this fund to advancing deep-tech innovations and high-impact indigenous manufacturing under the vision of Viksit Bharat 2047.
The PIB communication states that the RDI Fund was launched by the Prime Minister on November 3, 2025, and is managed by the Anusandhan National Research Foundation (ANRF) and the Department of Science and Technology (DST). BIRAC is designated as a Second Level Fund Manager for the biotechnology sector. The BIRAC-RDIF division is set up to ensure ring-fenced implementation of the fund for biotech projects.
What changed now: measures discussed and the operational status of BIRAC-RDIF
Related current affairs
- Cabinet approval and ongoing implementation of BioE3 policy: biomanufacturing, hubs and project funding
- Reshaping protein design with AI (text at bottom: ‘Scientists can now shrink and rewrite proteins with AI…’; includes ‘EXPERT EXPLAINS’ and ‘EXPLAINED’)
- MoHUA launches Operational Guidelines for Urban Challenge Fund (UCF)
- DBT-ISRO collaboration for space biotechnology and space biomanufacturing
- Establishment of Bio-AI Hubs and Biofoundries/biomanufacturing hubs under BioE3 through calls for proposals
- BioE3 strain resource centre at BRIC-NCCS Pune to enable indigenous microbial strains with freedom-to-operate
